In the media

<p>Erika Lopez, IRB Barcelona.</p>
25 Nov 2019 -

The newspaper La Tribuna de Albacete has interviewed IRB Barcelona researcher Erika López Arribillaga about a grant awarded to her on 24 September by the Spanish Association Against Cancer (AECC). López Arribillaga’s project aims to unravel the long-term effects of some chemotherapy treatments on colorectal cancer patients. 

 

Link to La Tribuna de Albacete

 

 

<p>Researchers at IRB Barcelona have identified these genetic footprints produced by some cancer treatments and have for the first time been able to calculate the genetic toxicity of some of these treatments. Claudia Arnedo, IRB Barcelona.</p>
25 Nov 2019 -

The newspapers El Mundo, La Vanguardia and Diari Ara, the TV station TV3 and the radio stationsCatalunya Ràdio andRAC1, among other media, have echoed on a study by the Biomedical Genommics lab, headed by Núria López, published in Nature Genetics. The study has for the first time determined the genetic mutations caused by various therapies used to treat cancer. “Studying the DNA damage caused by chemotherapies in patients’ cells is the first step towards understanding the relation between these mutations and the long-term side effects of these treatments,” says Oriol Pich, PhD student at IRB Barcelona and first author of the article.

 

 

 

 

Link to...

<p>Predictive decision trees optimized to decide if a cancer mutation will become visible to the immune system. Rik G.H. Lindeboom, Radboud University.</p>
25 Nov 2019 -

RTVE, the newspaper Heraldo de Aragón, and Diario Médico—the newspaper specialized in health—among other media, have echoed on a new algorithm, developed by researchers at IRB Barcelona in collaboration with the Centre for Genomic Regulation and the University of Radboud, that allows identification of those patients who are most likely to benefit from immunotherapy. Based on machine learning, the scientists have developed a tool that detects the genetic mutations that activate the immune system. This algorithm also identifies those people with certain hereditary diseases that would benefit from certain kinds of drug already on the market. The study was published in the journal Nature...

<p>Salvador Aznar Beniath, IRB Barcelona</p>
15 Nov 2019 -

The newspaper ABC, among other media, have reported on the “Premio Carmen y Severo Ochoa de Investigación en Biología Molecular 2019", which has been given to IRB Barcelona researcher Salvador Aznar Benitah. “This recognition is particularly special because it is the Carmen and Severo Ochoa Prize; you only have to take a look at the list of former awardees, all of them with an incredible career and who do first-rate science. It´s an honour for me to join this group,” said the researcher after being presented with the prize. 

 

 

<p>Carme Cortina, researcher at IRB Barcelona</p>
7 Nov 2019 -

“Cinc dies a...” broadcasted by La2 has devoted a programme to the day to day lives of all those who work at the Barcelona Science Park, ranging from researchers to admin staff and other service staff. Several members of the IRB Barcelona community participated in the programme. Lara Barrio, a researcher with the Growth Control and Development Lab, showed how studying the vinegar fly Drosophila can help us to understand human diseases. In the Colorectal Cancer Lab, the scientists Elena Sancho and Carme Cortina explained their research into colon cancer and metastasis. In addition, Silvia Frutos, Alumna of IRB Barcelona, commented on how she founded her company ProteoDesign seven years...

<p>Carme Cortina, postdoctoral fellow in the Colorectal Cancer Lab at IRB Barcelona.</p>
30 Oct 2019 -

Carme Cortina, postdoctoral fellow in the Colorectal Cancer Lab at IRB Barcelona, comments about new gene editing technique called “prime editing” in Diari Ara. Published last week in Nature, this novel approach can enhance DNA repair with unprecedented precision. Thanks to this technique, the authors of the study have managed to repair the DNA of cells affected by conditions such as sickle cell disease and Tay-Sachs disease, the latter a disorder that destroys nerve cells and leads to motor impairment and deafness. “It is a beautiful piece of work based on a brilliant idea and it significantly improves previous gene editing methods,” says Cortina.

...
<p>Toni Gabaldón, ICREA researcher at IRB Barcelona and the BSC-CNS.</p>
21 Oct 2019 -

Innovaspain, the newspaper specialized in science and innovation, has interviewed Toni Gabaldón, ICREA researcher at IRB Barcelona and the BSC-CNS, regarding his work on evolutionary genomics. "Genomics is expected to play an important role in the medicine of the future," says the scientist. "The true hope is that genomics emerges not only as a means to detect diseases or define a treatment but as a therapeutic tool through which to manipulate genes through transfer technologies or gene modification," he goes on to say.

 

Link to Innovaspain

<p>Roger Gomis, head of the Growth Control and Cancer Metastasis Lab at IRB Barcelona and founder of Inbiomotion.</p>
15 Oct 2019 -

The economics newspaper Expansión Catalunya has echoed the forthcoming publication of the results of a clinical assay of the MAF-Test, a diagnostic test for breast cancer patients developed by Inbiomotion, a spin-off from IRB Barcelona set up in 2010 by the researcher Roger Gomis. The results are expected to be out in November. This test may have the capacity to identify those breast cancer patients who would benefit from treatment with bisphosphonates, a class of drugs used to treat non-metastatic breast cancer, but whose administration can in many cases be counterproductive. If the results are positive, it is hoped that this test will reduce mortality...

<p>The researcher Meritxell Teixidó has been interviewed on the TVE2’s documentary ¡Qué animal!</p>
15 Oct 2019 -

Meritxell Teixidó, a researcher at IRB Barcelona, has been interviewed on the TVE2’s documentary ¡Qué animal! about her work with peptides from scorpion and bee venom in search of drugs that can reach the brain. "These poisons are able to reach the brain, which explains their toxicity. It is precisely this capacity  that attracts us to examine their applications," explains Teixidó. 

 

Link to TVE

 

<p>The director general of BIST, Gabby Silberman, and the directors of the seven BIST centers planted a tree at the entrance of the BIST headquarters as a symbolic gesture with which the institution joins the global mobilizations against the climate crisis.</p>
1 Oct 2019 -

The radio station COPE and the newspapers La Vanguardia and La Razón, among others, have reported on the statement of 7 BIST centres, among them IRB Barcelona, in favour of global action against the climate crisis. The scientists join the global movement against the climate crisis and the world strike called  on 20 September, in addition to presenting a statement in which they confirm that the evidence of climate change is “solid”. In this statement, they make an urgent call for "personal, social and political actions" to prevent “catastrophic effects and “devastating consequences " if climate change is not reversed.

Link to...